Navigation Links
Cancer Patients Turn Their Backs on Canadian Health Minister

Medicare is a hot topic in the presidential elections in US. The issue is raging in neighbouring Canada too .

And they dont allow politicians to get away with glib talk. As the countrys Health Minister George Smitherman was waxing eloquent on the governments commitment to medicare, a group of cancer patients in the audience stood up and turned their backs.

About 25 protesters wore shirts bearing the slogans "Cancer patients need a credit card'' and "Where did medicare go?'' at a groundbreaking ceremony for a new home for patients with terminal illnesses at Toronto's Trillium Health Centre.

Protest organizer Roman Gawur said Ontario ranks ninth out of ten provinces for the amount of funding it puts toward cancer drugs.

Gawur said that while he supports the new palliative care home, he thinks the government should also be investing in people who have the chance to live longer.

Some patients are even going bankrupt simply trying fund the cost of their treatment, he said.

"They're spending anywhere from $40,000 to $60,000 for medically necessary drugs to be injected in the hospital, which is a violation of the Canada Health Act,'' he said.

"There are just a lot of folks here who are really struggling to pay for something that should be covered by the government."

Gawur, 57, had to pay $2,700 every two weeks while he was undergoing treatment.

One of the protesters said he has spent over $40,000 on cancer drugs that aren't funded by the Ontario government.

He travels to Buffalo every week for injections of a drug that isn't available in Canada.

Fellow protester Ivo Camilleri said cancer patients in Ontario shouldn't have to go to other provinces or countries to get proper treatment.

"I'm 73 years old. I have three children. Why should I have to leave my home here, away from my three children with their families and my grandchildren just to stay alive?'' he asked.

"I think that is most unfair."

What next the helpless patients could do to impress upon the government to be more caring, one can only wait and see.


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: